Dr. Reddy’s, Russia Get India Approval for Human Vaccine Trial

Dr. Reddy’s Laboratories Ltd. and Russia’s sovereign wealth fund got approval to conduct human clinical trials of their coronavirus vaccine in India, according to an emailed statement from one of the vaccine developers.

The phase 2/3 trial will be a multi-center and randomized controlled study that will include safety and immunogenicity, according to the statement by the Russian Direct Investment Fund.